Ashley Mathai
Psychiatric/Mental Health · Staten Island, NYNPI 1306330295
Payments from drug & device makers
Across 128 payments — averaging $61.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$790
- E.r. Squibb & Sons, L.L.C.$629
- Axsome Therapeutics, Inc.$363
- plus $1K from 11 others
What the payments were for
- Food & beverage$7,907100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 20 | $1,667 |
| AbbVie | 22 | $1,575 |
| Otsuka America Pharmaceutical, Inc. | 25 | $1,403 |
| Teva Pharmaceuticals USA, Inc. | 8 | $790 |
| E.r. Squibb & Sons, L.L.C. | 5 | $629 |
| Axsome Therapeutics, Inc. | 3 | $363 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $262 |
| Lundbeck LLC | 11 | $260 |
| Pfizer | 2 | $239 |
| Johnson & Johnson | 8 | $179 |
| Alkermes, Inc. | 9 | $172 |
| Gilead | 2 | $130 |
| GSK | 1 | $124 |
| Almatica Pharma LLC | 2 | $53 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$1,206
- VRAYLAR$1,200
- COBENFY$629
- REXULTI$499
- Austedo XR$493
- ABILIFY MAINTENA$489
- Auvelity$246
- UZEDY$246
- NURTEC ODT$239
- CAPLYTA$127
- TRELEGY ELLIPTA$124
- ABILIFY ASIMTUFII$121
- Symbravo$117
How this compares
$7,907 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 38 | $1,815 |
| Divalproex Sodium | 35 | $585 |
| Haloperidol | 17 | $545 |
| Olanzapine OdtOlanzapine | 12 | $439 |
| Benztropine Mesylate | 18 | $137 |
| Aripiprazole | 13 | $107 |
| Risperidone | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Staten Island
- Kevin SiewersStaten Island$155K
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.